Stockscreener 앱 받기
10.58
5.70%
-0.64
Eikon Therapeutics Inc 주식(EIKN)의 최신 뉴스
Is Eikon Therapeutics, Inc. (EIKN) Stock a Biotech Growth Opportunity Despite Limited Q1 Updates? - Yahoo Finance
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS:EIKN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Value Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS:EIKN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 2000 Growth Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell 3000E Growth Benchmark - marketscreener.com
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to Russell Microcap Index - marketscreener.com
Eikon Therapeutics to join Russell 3000 index - MSN
Eikon Therapeutics to Join the Russell 3000 Index - marketscreener.com
Enterprise value to EBITDA forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics เตรียมเข้าคำนวณในดัชนี Russell 3000 หลังการปรับโครงสร้างดัชนีประจำปี - Moomoo
Price to sales forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics, Inc. Actuals & Estimates (NASDAQ:EIKN) - TradingView
Price to book forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics to join Russell 3000 Index on Friday By Investing.com - Investing.com South Africa
Price to earnings forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Enterprise value to EBIT forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Price to book forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Price to sales forward of Eikon Therapeutics, Inc. – BOATS:EIKN - TradingView
Eikon Therapeutics to join Russell 3000 Index on Friday - Investing.com
Eikon Therapeutics to Join Russell 3000 Index Following Annual Reconstitution - Quiver Quantitative
Eikon Therapeutics to Join the Russell 3000® Index - The Manila Times
EIKN Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Price to earnings forward of Eikon Therapeutics, Inc. – NASDAQ:EIKN - TradingView
Eikon Therapeutics, Inc.(NasdaqGS: EIKN) added to S&P Global BMI Index - marketscreener.com
Eikon Therapeutics Ord Shs (EIKN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Eikon Therapeutics Ord Shs (EIKN) Institutional Confidence - TradingKey
Eikon Therapeutics (EIKN) Slips 1.23% as Stock Tests Key Support at $9.13Entry Point Alerts - dars.gov.et
IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO - BioSpace
Eikon Therapeutics Ord Shs (EIKN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eikon Therapeutics: Buy TLR Combinatory Potential Only After Lock-Up Expiry - Seeking Alpha
Soros opened a brand new EIKN position — moomoo's New tab ca...moomoo Community - Moomoo
Eikon Therapeutics: Initiating Coverage With A Cautious Buy Rating (NASDAQ:EIKN) - Seeking Alpha
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Eikon Therapeutics Appoints Ma. Fatima Francisco to Board - The Globe and Mail
New director and stock option grant at Eikon Therapeutics (NASDAQ: EIKN) - Stock Titan
EIKN Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue ChallengesLow Estimate Range - dars.gov.et
Eikon Therapeutics (EIKN) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Eikon Therapeutics discloses new USP1 inhibitors - BioWorld News
Eikon Therapeutics, Inc. Announces Appointment of Ma. Fatima D. Francisco as Independent Director and Compensation Committee Member, Effective June 15, 2026 - marketscreener.com
Eikon Therapeutics appoints Francisco to board of directors By Investing.com - Investing.com Nigeria
Eikon Therapeutics appoints Francisco to board of directors - Investing.com India
Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors - The Manila Times
Eikon Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.8, Implies 158% Upside - TradingView
BofA Securities Maintains Eikon Therapeutics(EIKN.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Cantor Fitzgerald reiterates Overweight on Eikon stock By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Overweight on Eikon stock - Investing.com UK
2.64%
자본화:
|
볼륨(24시간):